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Renal injury in DOCA-salt hypertensive CS-sufficient and C5-deflcient
mice. We induced hypertension by uninephrectomy and treatment with
desoxycorticosterone (DOCA) and 1% NaCI in the drinking water in
congenic mice that differ in the single gene locus responsible for the
presence or absence of the complement component CS and compared
them to uninephrectomized normotensive (no DOCA-NaCI) mice. In
contrast to C5-sufficient (C5S) mice, CS-deficient (C5D) mice can
neither generate C5a nor assemble C5b-9. After four weeks of treat-
ment, DOCA-C5S and -C5D mice developed similar degrees of hyper-
tension; mice receiving no DOCA remained normotensive. Only hyper-
tensive mice developed glomerular injury. Hypertensive DOCA-C5D
mice developed more glomerular capillary loop dilatation and larger
glomerular capillary tuft volumes than DOCA-C5S mice (1.0 0.1 vs.
0.7 0.03 x 106 sm3, respectively, P < 0.05). However, DOCA-C5S
mice, compared to DOCA-CSD mice, had significantly more glomerular.
cell proliferation (64.5 2 vs. 42 3 nuclei/glomerulus), cell necrosis
(injury score 22 I vs. 17 I), extracapillary proliferation (26 4 vs.
2.5 2% ofglomeruli) and proteinuria (5.9 0.8 vs. 3.7 0.5 mg/24 hr;
all P < 0.05). By immunofluorescence microscopy both DOCA-C5S and
-C5D had mesangial C3 deposits but only DOCA-C5S mice had C9
deposits. After 16 weeks of DOCA-NaCI C5S mice, in comparison to
C5D mice, had more severe glomerulosclerosis (injury score 50 6 vs.
12 4), proteinuria (16.6 0.1 vs. 9 0.1 mg/24 hr), and renal
insufficiency (serum creatinine 0.25 vs. 0.15 mg/dl), all P < 0.05. These
changes occurred despite levels of hypertension that were similar in
DOCA-NaCl C5S and C5D throughout the whole study period. We
conclude that CSa and/or C5b-9 may play an important role in hyper-
tensive glomerular injury. Moreover, these studies demonstrate that
differences in host responses may determine target organ susceptibility
to similar injurious mechanisms.
Studies on the role of the complement system in the patho-
genesis of tissue damage have recently focused on the partici-
pation of the late-acting components CS through C9 (C5-9) in
the production of injury in several disease states [1—7]. C5a is a
chemoattractant and anaphylatoxin of major biological signifi-
cance [8]. In addition, in the kidney C5a increases glomerular
efferent arteriolar resistance which results in elevations in
intraglomerular capillary pressure [91. Membrane-bound CSb-9,
also designated membrane attack complex or MAC, causes cell
lysis as the result of its interaction with membrane lipid bilayers
[4—7]. Recently, it has been demonstrated that the MAC in
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sublytic amounts can stimulate resident glomerular cells to
release inflammatory mediators, reactive oxygen species, and
an 1L1-like growth factor [10—12].
Several studies have demonstrated deposition of C5b-9 and
C9 neoantigen, a marker of terminal complement activation, not
only in tissues damaged by immune mechanisms [1, 21, but also
in tissues injured by nonimmunological mechanisms [2]. How-
ever, immunohistochemical demonstration of C5b-9 does not
necessarily imply that C5b-9 is responsible for producing tissue
damage, particularly in lesions where C5b-9 was found to
colocalize with the S protein [3]. In these circumstances it is
unknown whether the S protein was added to C5b-9 locally after
C5b-9 had an opportunity to induce tissue damage or whether
SC5b-9 was passively deposited from the circulation [3J. Ex-
perimentally, the pathogenetic role of C5-9 in the production of
tissue injury either through the action of C5a or C5b-9 has been
conclusively demonstrated in several immune-mediated models
of renal disease [4, 5, 13].
Recent studies have shown that the hemodynamic stress of
hypertension may lead to glomerular and vascular injury in the
kidney [14, 15]. Furthermore, we and others have shown
experimentally that immune injury and hypertension synergis-
tically interact in the progression of glomerular injury [16—18].
Clinically, hypertension often accelerates the progression of
renal disease [19, 20]. However, the basic mechanisms by
which hypertension induces vascular injury are still unclear.
Recent studies demonstrated the presence of C9 neoantigen in
renal blood vessel walls as well as in juxtaglomerular and
mesangial regions in hypertension and diabetes mellitus [2], two
diseases not mediated by immune mechanisms. These findings
suggested to us that in these conditions C5-9 might be involved
in the amplification of tissue injury. Therefore, we thought it
important to investigate whether C5-9 plays a role in the
progression of renal damage during the course of experimental-
ly-induced hypertension.
We induced hypertension by uninephrectomy and treatment
with desoxycorticosterone acetate (DOCA) and 1% NaCI in the
drinking water in groups of congenic mice which differ in the
single gene locus responsible for the presence or absence of CS.
This experimental model was chosen because: a) CS-deficient
mice can neither generate CSa nor assemble the CSb-9 complex,
and b) DOCA-salt hypertension results in high glomerular
capillary pressure accompanied by severe glomerular injury
[21, 22]. The results showed that, at similar levels of systemic
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hypertension, CS-deficient (C5D) mice developed significantly
less morphologic damage, proteinuria and renal insufficiency
than normocomplementemic, C5-sufficient (C5S) mice.
Methods
Five-week-old B. l0.D2NSN C5S and B. l0.D2OSN C5D male
mice were obtained from Jackson Laboratory (Bar Harbor,
Maine, USA). Mice were fed standard mice chow (Ralston
Purina Company, St. Louis, Missouri, USA). Blood pressure
(BP) was measured in unanesthetized mice by the tail-cuff
method with an IITC apparatus (IITC Life Science, Woodland
Hills, California, USA). The BP was measured during the
morning in a quiet environment every two weeks [17]. The
average of three successive readings was recorded. Mice were
anesthetized with 1.5 mg of pentobarbital intraperitoneally and
underwent right nephrectomy through a midline incision. Three
days after uninephrectomy the baseline BP was determined and
then C55 and C5D mice were assigned randomly to experimen-
tal groups that received 6 mg of desoxycorticosterone acetate
(DOCA; Ciba, Summit, New Jersey, USA) subcutaneously
once a week and 1% NaCI as drinking water or to control
groups which did not receive DOCA and were given tap water.
Total hemolytic complement assays were performed to con-
firm the C5S and C5D phenotypes utilizing a microtiter modi-
fication of a CH5O assay described previously [23]. Rabbit red
blood cells were sensitized with goat hemolysin (Cappel Labo-
ratories, Inc., Cochranville, Pennsylvania, USA) and washed in
cold gelatin-Veronal buffered saline. Mouse blood was obtained
from the retroorbital plexus and placed immediately on ice.
Serum dilutions were then added to the sensitized red blood
cells and incubated for one hour at 37°C. At serum dilutions
from C5S mice causing lysis at 80 to 100% of the complete lysis
control, sera from C5D mice had negligible hemolytic activity.
Serum creatinine, 24-hour urinary protein excretion and renal
tissue samples were obtained from mice 4 and 16 weeks after
initiation of the experimental protocol. For urine collection
mice were kept in metabolic cages. Total urinary protein was
determined by the Biuret method [16, 17] and serum creatinine
by a modified colorimetric Jaffe reaction [16, 17]. Groups of
DOCA-treated C5S mice (N = 12) and C5D mice (N = 12) as
well as controls C5S (N = 9) and C5D (N = 10) mice were bled
and sacrificed four weeks after initiation of the study. In
addition, groups of C5S (N = 11) and C5D (N = 10) mice
received DOCA and 1% NaCI as drinking water for 16 weeks, at
which time they were bled and sacrificed for examination of
renal tissues.
Renal tissue was obtained for light, immunofluorescent and
electron microscopy according to techniques previously de-
scribed [16, 17]. Tissue samples were evaluated by immunoflu-
orescent and light microscopy independently by two investiga-
tors (LR, AJF) without prior knowledge of the group to which
the mice belonged. Coded samples prepared for electron mi-
croscopy were studied by one investigator (NS).
The following light microscopy features were evaluated: a)
intracapillary cellular proliferation; b) capillary loop aneurysms
characterized by dilatation of capillary 1oops greater than two to
three times normal capillary diameter; c) glomerulosclerosis,
defined as the disappearance of cellular elements from the tuft,
collapse of the capillary lumen, and folding of the glomerular
basement membrane with entrapment of amorphous material;
d) cellular necrosis evidenced by loss of recognition of cellular
membranes and by karyorrhexis; e) extracapillary cellular
proliferation (crescents); and f) tubulointerstitial changes, in-
cluding tubular atrophy, interstitial fibrosis and cellular infil-
trates. Morphologic changes a-d were quantitated on a scale of
Ito 4 [17]. A score of 1 was equivalent to 25% of the glomerulus
affected by the particular morphologic change, and 4 repre-
sented involvement of 100% of the glomerulus. Intermediate
values were assigned a value of 0.5. An injury score was then
obtained by multiplying the severity of the change by the
percentage of glomeruli with the same severity of change [17].
The extent of injury for each individual tissue specimen was
then obtained by the addition of these scores. Morphologic
changes e and f were expressed directly as the percentage of
glomeruli (e) or tubulointerstitial tissue (f) involved. As the
injury score for individual tissue specimens derived by each
investigator varied from 15 to 20%, the scores obtained by the
two investigators were averaged.
In addition in blinded tissue samples of control and DOCA-
C5S and -C5D mice sacrificed at four weeks, we counted
glomeruli nuclei and measured glomerular volumes in 30 gb-
meruli randomly selected from six mice in each group. Glomer-
ular tuft volumes were measured by stereobogical point count-
ing according to techniques previously described [24, 25]. For
this purpose a projection head was fitted to the microscope for
the projection of an 81 point grid with 1 cm between interjec-
tions (total magnification x530). The mean glomerular volume
is obtained as V(G) = x [A(G)]312 where 1.38 pertains to
spheres, k (a distribution coefficient) is taken to be 1.10 [24, 25]
and A(G) is the glomerular cross-sectional area. Glomerular
nuclei and volumes were not determined in 16-week-old mice
because the presence of glomerulosclerosis in DOCA-C5S mice
would have interfered with the measurements [26].
For immunohistologic studies renal tissue was treated with
monospecific antisera (rabbit or goat) against mouse IgG, 1gM,
C3, albumin and fibrin (Cappel Laboratories). Deposits of C9
were identified with a rabbit antiserum raised in our laboratory
against purified rat C9 that was found to cross-react with mouse
C9. The antisera were either fluorescein labeled or unlabeled
and then reacted by indirect staining. Monoclonal antibodies
(from Dr. Jeffrey Platt, Dept. of Pediatrics, University of
Minnesota) of the following specificities were used to search for
lymphocyte populations and monocytes in renal tissue: Lyt 1
(CD5) and Lyt 2 (CD8) (Becton Dickinson, Mountain View,
California, USA), Thy I and MAC I (CR3) (Boehringer, Indi-
anapolis, Indiana, USA), and GK 1.5 (CD4) and IL2R (Amer-
ican Tissue Culture Collection, Washington, D.C., USA). Four
micron frozen sections were prepared and mounted on glass
slides, air dried, and acetone fixed, Sections were reacted with
appropriate primary antibody reagents and then with fluoresce-
in-conjugated goat F(ab')2 anti-rat IgG. For immunofluorescent
enhancement, a second fluorochrome of F(ab')2 rabbit IgG
against the first fluorochrome layer was used [16, 27]. Control
sections were incubated with myeloma-derived Ig of the same
isotipe as the monoclonal antibody. Sections were also reacted
with rhodamine-conjugated rabbit antisera to type IV collagen
and laminin [27]. None of the antisera reacted with glomerular
cells from normal C5S or C5D mice.
Data were expressed as mean SEM. Data from the different
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Table 1. Effect of treatment with DOCA- I% NaC1 on blood pressure, protein excretion, serum creatinine and body weight of C5-sufficient and
CS-deficient mice
Group
DOCA-
1% NaCI
Duration of treatment
4 Weeks 16 Weeks
BP
mm Hg
U prot
mg/24 hr
Sr
ng/dl
Body wt
g
BP
mm Hg
U Prot
mg/24 hr
S.
mg/dl
Body wt
g
cssa No 95 4 2.6 0.3 0.1 22 0.3 — — — —
C5Sb
(N = 9)
Yes 148 10 5.9 0.8 0.l 20 0.5 157 3 16.6 0.1 0.25 0.03 31 1
C5DC
(N=9)
No 96 3 2.0 0.3 0.1 21 0.6 (N=11)— — — —
C5Dd
(N = 10)
Yes 143 7 3.7 0.5 0.l 19 0.4 157 4 9 0.1 0.15 0.02 33 0.5(N=l0) (N=10)
Values are mean SEM. Abbreviations are: C5S, CS-sufficient mice, C5D, CS-deficient mice; BP, blood pressure; U prot, urine protein: Scr,
serum creatinine; Body wt, body weight; N = number of mice; —, not done.
The following comparisons between groups yielded P < 0.05:
At 4 weeks: BP, a vs. b, d
c vs. b, d
U Prot b vs. a, c, d
At 16 weeks: U Prot, b vs. d
Scr, b vs. d
4 weeks vs. 16 weeks: U prot, b and d
Sr, b
Body wt, b and d
groups were compared by ANOVA using the Scheffe F-test. P
<0.05 was considered significant.
Results
Mice studied at four weeks
Control C5S and C5D mice remained normotensive with
blood pressures of 95 4 mm Hg and 96 3 mm Hg,
respectively. C5S and C5D mice which received DOCA-NaCI
became equally hypertensive, with blood pressures of 148 10
mm Hg and 143 7 mm Hg, respectively. During this period
three C5S and two C5D mice died. The surviving mice in all
groups appeared healthy and achieved similar body weights
(Table 1). Compared with respective control groups, DOCA-
C5S but not DOCA-C5D mice had significant increase in urine
protein excretion (Table 1). The urinary protein excretion of
DOCA-C5S mice was higher than that observed in DOCA-C5D
mice (Table 1). All groups had similar serum creatinine (Table
1).
The kidney weight of control CSS and C5D was similar, 0.16
0.01 versus 0.16 0.02 g, respectively. The kidney weight of
CSS and C5D mice which received DOCA was significantly
increased compared with the respective control mice, 0.31
0.03 and 0.28 0.02 g, respectively. Light microscopy showed
normal glomerular and interstitial architecture in normotensive
control C5S and C5D mice. Morphologically, glomeruli of
normotensive C5S and C5D mice had similar number of gb-
merular cells (32 2 vs. 27 I nucleilglomerulus) and
glomerular volumes (0.27 0.01 vs. 0.23 0.02 x l0' tm3,
respectively; Table 2). Hypertensive DOCA-C5S and DOCA-
C5D mice developed morphologic abnormalities (Tables 2 and
3). Glomeruli of DOCA-C5S mice showed diffuse intraglomer-
ular capillary proliferation (64.5 2 nuclei per glomerulus)
which affected primarily the mesangium. Cellular necrosis
Table 2. Glomerular nuclei number and glomerular volumes in
normotensive and hypertensive C5S and C5D mice after 4 weeks of
uninephrectomy or uninephrectomy plus DOCA-1% NaCI
respectively
Glomerular
Nuclei/ volume
Group DOCA glomerulus x IO un3
C5S No 32 2 0.27 0.01
C5D" No 27 0.8 0.23 0.02
C5SC Yes 64.5 2 0.61 0.02
C5D" Yes 42 3 1.0
N = 6 in each group. Values are mean SEM.
The following comparisons between groups yielded P < 0.05 for both
nuclei/glomerulus and for glomerular volumes:
a vs. c and d
b vs. c and d
c vs. d
(score 22 1) was randomly distributed among glomerular
lobules; 26% 4 of glomeruli had cellular crescent formation
(Figs. I and 2). The tubules and interstitium were well pre-
served. These morphologic changes contrasted with those
observed in hypertensive DOCA-C5D mice. Although DOCA-
C5D mice had intracapillary proliferation and cellular necrosis,
these changes were 35% and 23% less severe than in DOCA-
C5S mice, respectively (Tables 2 and 3). Crescents were
present only in 2.5% of gbomeruli of DOCA-C5D mice. How-
ever, striking aneurysmal dilatation of capillary ioops equiva-
lent to 2 to 3 normal capillary loops were more evident in
DOCA-C5D (score 112 10) than in DOCA-C5S (score 53 7)
mice (Fig. 2). The glomerular capillary volume of hypertensive
DOCA-C5S and DOCA-C5D was significantly increased com-
pared with the respective control mice (Table 2). However, the
gbomerular capillary volumes of DOCA-C5D mice were signif-
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Table 3. Renal pathological changes in CS-sufficient and CS-deficient
mice given DOCA-1% NaCI for either 4 or 16 weeks
Duration of treatment
4 Weeks 16 Weeks
C5SC C5D"cssa C5Db
Pathological changes (N = 9) (N = 10) (N = 11) (N = 10)
Glomerular
Cellularity 137 9 87 6 107 7 78 7
Cell necrosis 22 I 17 1 20 2 10 2
Crescents 26 4 2.5 2 16 2 2.5 2
Capillary dilatation 53 7 112 10 16 5 107 8
Sclerosis 0 0 50 6 12 4
Interstitial 8 2 2.5 2 23 2 5 2
Values are mean SEM. Abbreviations are: C5S, CS-sufficient mice;
CSD, CS-deficient mice; N, number of mice; cellularity, necrosis,
sclerosis and capillary dilation are expressed as injury scores; crescents
and interstitial changes are expressed as percent of glomeruli or
interstitium involved, respectively. Normotensive C5S and CSD mice
had normal glomeruli and interstitium both at 4 and 16 weeks.
The following comparisons between groups yielded P < 0.05:
Cellularity: a vs. b, c, d and c vs. d
Cell necrosis: a vs. b, d and c vs. d
Crescents: a vs. b, c, d and c vs. d
Capillary dilatations: a vs. b, c, d and c vs. d
Sclerosis: c vs. a, b, d
Interstitial changes: a vs. b, c, and c vs. d
icantly larger than those in DOCA-C5S (1.0 0.1 vs. 0.61
0.02 x 10 m3, respectively). Tubulointerstitial changes were
minimal in both C5S and C5D mice.
By immunofluorescence microscopy, staining with all anti-
sera was negative in normotensive control mice. In hyperten-
sive mice staining for IgG was negative. Staining for 1gM, fibrin
and C3 was present primarily in the mesangium and in some
peripheral glomerular capillary loops of both DOCA-C5S and
DOCA-C5D mice (Fig. 3). Fibrin was present in crescents. The
intensity of 1gM and fibrin was greater in C5D mice, particularly
in the mesangium and peripheral capillary loops. These animals
also had C3 deposition in the subendothelium of dilated glomer-
ular capillaries. C9 was present in a focal and segmental
distribution in capillary loops and mesangium of DOCA-C5S
mice but was absent in DOCA-C5D mice (Fig. 4). The extent of
mesangial expansion described above by light microscopy was
further assessed by immunofluorescent staining for type IV
collagen and laminin which are known to be present in the
mesangium. Compared to normotensive mice both groups of
hypertensive mice had expanded distribution of type IV colla-
gen and laminin within the mesangium. No significant glomer-
ular infiltration of lymphoid cells was detected in either DOCA-
C5S or -C5D mice; however, positive staining for MAC 1 was
observed in some crescents.
By electron microscopy normotensive C5S and C5D mice
had normal glomeruli. In hypertensive C5S mice glomeruli
showed proliferation of mesangial cells as well as widening of
mesangial channels. The proliferation of mesangial cells en-
croached upon the capillary lumens leading to a reduction in the
lumen of some capillary loops and in others to a compensatory
dilatation of the capillary loop towards the periphery (Fig. 5). In
some glomeruli extracapillary proliferation of epithelial cells in
the form of crescents could be observed. In occasional glomer-
uli of C5S mice gaps in the glomerular basement membrane
were seen in association with crescent formation (Fig. 5). Focal
fusion of epithelial cells foot processes was present in some
glomeruli. Fibrillar material with the appearance of fibrin was
present in the crescents but was rare within capillary loops.
Neither polymorphonuclear leukocytes nor monocytes could be
identified within the mesangial areas or in their vicinity. On the
other hand some mononuclear cells with the appearance of
monocytes could be identified in crescents in proximity to
proliferating epithelial cells. As observed by light microscopy,
intraglomerular as well as extraglomerular capillary prolifera-
tion was less marked in hypertensive C5D mice. In glomeruli of
DOCA-C5D mice strikingly dilated capillary loops without
evidence of peripheral capillary wall rupture were observed.
The dilatation appeared to be due to stretching of the capillary
loops themselves which resulted in tears in the anchoring points
of the mesangium (Fig. 6). However, contrasting with the
glomeruli of C5S mice, the dilated capillary loops were not filled
by proliferating mesangial cells. In many capillary loops of both
DOCA-C5S and DOCA-C5D the endothelium was focally dis-
rupted leading to subendothelial accumulation of proteinaceus
material. The visceral epithelial cells of C5D mice were remark-
ably well preserved despite being stretched by the dilated
glomerular capillaries (Fig. 6).
Mice studied at 16 weeks
The severity of hypertension was similar in CSS and C5D
mice throughout the study period. Moreover, the blood pres-
sure of mice which received DOCA-NaC! for 16 weeks was not
significantly different from the blood pressure of mice sacrificed
after only four weeks of DOCA-NaCl (Table I). The urinary
protein excretion of both DOCA-C5S and DOCA-C5D mice
was higher at 16 weeks than at four weeks. However, the
urinary protein excretion of DOCA-C5S mice was markedly
higher than that of DOCA-C5D mice (Table 1). The serum
creatinine, which at four weeks was similar in all groups, at 16
weeks was significantly higher in hypertensive C5S than in C5D
mice (Table 1).
By light microscopy morphological differences similar to
those observed between hypertensive C5S and C5D mice at
four weeks were also seen at 16 weeks. Sixteen week DOCA-
C5S mice had intraglomerular capillary proliferation and occa-
sional cellular necrosis (Table 3). However, the glomerular
crescents were less cellular and tended to be more fibrotic.
Glomerulosclerosis, which was absent at four weeks, could be
seen in 16 week DOCA-C5S mice (score 50 6), particularly in
corticomedullary glomeruli. In DOCA-C5D mice glomerular
capillary proliferation, necrosis and crescents were less severe
than in DOCA-CSS mice (Table 3). Capillary aneurysmal bal-
looning similar to that observed at four weeks was still observed
at 16 weeks in DOCA-C5D mice; however, glomerulosclerosis
was minimal in these mice (score 12 4, Table 2).
Discussion
These studies were performed to investigate the possible
participation of the terminal complement components in hyper-
tensive renal injury. C5-9 can produce renal damage through the
chemotactic and anaphylatoxin properties of C5a or through the
effects of C5b-9 on membranes [4—7]. Although it is uncertain
whether CSb-9 can directly damage extracellular matrices such
as glomerular basement membranes, recent work indicates that
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Fig. 1. Glomerulus from an hypertensive CS-sufficient mouse showing an extracapillary glomerular crescent. Magnification X600.
Fig. 2. A. Glomerulus from hypertensive DOCA-NaCI treated C5-deficient mouse featuring extensive glomerular capillary aneurysms but little
cellular proliferation. Magnification x400. B.Glomerulus from similarly hypertensive C5-sufficient mouse showing glomerular capillary endothelial
proliferation, capillary loop narrowing, and mesangial proliferation. Magnification x470.
C5b-9 in sublytic amounts is able to trigger cellular reactions tors [10—12], reactive oxygen species [121, and 1L1-like growth
that are potentially capable of producing renal injury [5, 13]. factor [11], as well as serotonin and thromboxane B2 by
Sublytic amounts of C5b-9 have been shown to induce release platelets and macrophages [28, 291. In addition C5a can raise
by resident glomerular mesangial cells of inflammatory media- intraglomerular capillary pressure [9].
C.
9,
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Fig. 3. linmunofluorescent microscopy of glomerular
lesions in hypertensive DOCA-NaCl treated C5 -deficient
(A, C, E) and CS-sufficient mice (B, D, F, G). Mesangial
deposition of 1gM (A, B) and fibrin (C, D) were more
extensive in C5-deficient mice (A, C). Lacey exudates of
C3 within glomerular capillary aneurysms were evident in
C5-deficient mice (E) compared to minimal granular
mesangial deposits in C5-sufficient animals (F). Focal and
segmental deposition of C9 in capillary loops and mesangial
areas was present in C5-sufficient (G) but not in C5-
deficient mice (not shown). Magnifications x400 to 470.
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Fig. 4. Electron micrograph of a glomerulus from a hypertensive DOCA-NaCI C5-sufficient mouse shows proliferation of ,nesangial cells (M)
which impinge on capillary lumens (CL). Magnification x3840.
By means of immunohistochemical methods small amounts
of C5b-9 were found in normal human tissues, possibly due to
binding of C5b-9 to remnant cell membranes during normal
senescence [2, 5, 301. However, studies in disease states have
shown large deposits of C5b-9 not only in tissues damaged by
immune mechanisms [I, 2], but also in tissues injured by
nonimmune mechanisms, such as in diabetes mellitus and
hypertension [21. Although indirect, these observations suggest
a possible pathogenic role of complement in these conditions.
Therefore we postulated that in hypertension complement
might be involved in amplification of renal injury. The basic
mechanisms that cause vascular injury in hypertension are still
unclear. Studies have suggested that the hemodynamic stress of
hypertension can lead to glomerular and vascular injury in the
kidney [14—19]. Furthermore, we and others have shown exper-
imentally that immune injury and hypertension interact syner-
gistically in the progression of glomerular injury [16—18]. Clin-
ically, hypertension often accelerates the progression of renal
disease [19, 20, 30, 31]. In hypertension, damaged endothelial
and subendothelial structures might initiate in situ complement
activation. Indeed, previous studies have shown that damaged
cells can bind Clq and generate stable C3 convertases [32] and
that noncomplement proteolytic enzymes can activate CS [33].
To explore whether the terminal complement components
play a pathogenetic role in hypertensive renal disease we
compared the degree of renal injury in a model of hypertension
in C5S and C5D mice. We induced hypertension by uninephrec-
tomy-DOCA and 1% NaCI in drinking water in congenic mice,
which differ in a single locus responsible for the presence or
absence of C5, and compared them with uninephrectomized
normotensive (no-DOCA/NaCl) mice. CSD mice can neither
generate C5a nor form the C5b-9 complex. In the rat, DOCA-
salt hypertension results in elevated glomerular capillary pres-
sures, as demonstrated by micropuncture techniques [22], and
severe glomerular injury [21, 22].
In the present studies, similar levels of hypertension devel-
oped after four weeks of DOCA in C5S and C5D mice (Table 1).
Uninephrectomized C5S and C5D mice receiving no DOCA
remained normotensive. Both DOCA-C5S and -C5D mice de-
veloped glomerular injury. However, DOCA-C5S mice had
significantly more intraglomerular capillary proliferation, cellu-
lar necrosis and extracapillary crescents than DOCA-C5D
mice.
Increased glomerular capillary volumes and dilatation of
capillary loops were particularly striking in DOCA-C5D mice.
Since identical capillary changes have been observed in DOCA-
t 'j:t
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Fig. 5. Electron micrograph of a gloinerulus from a hypertensive DOCA-NaC! cs-sufficient mouse shows rupture (gap between arrows) of the
glomerular basement membrane. Fibrin (F) is present in adjacent capillary lumens (CL) and urinary space. Visceral epithelial cell process (Ep)
protrudes through the gap in the glomerular basement membrane. Magnification X 14800.
salt rats with high intraglomerular capillary pressure [22],
similar mechanisms might be operative in hypertensive DOCA
mice. By electron microscopy glomerular capillary dilatation in
DOCA-C5D mice was accompanied by thinning of the mesan-
gium as well as rupture of the mesangial anchoring points of
capillary loops, a process similar to the "mesangiolysis" de-
scribed in rats given Habu snake venom [34]. Moreover, in the
rat administration of rabbit anti-thymocyte serum reactive with
Thy 1-like antigen caused mesangial injury (mesangiolysis) fol-
lowed by mesangial cell proliferation [35]. In this model, both
the mesangial cell injury as well as the subsequent proliferative
response appear independent of leukocytes but dependent upon
MAC formation [35, 36]. Thus in experimental models in which
mesangial disruption occurs [34], the rupture zone is quickly
filled by proliferating mesangial cells. This may explain why in
hypertensive C5S mice the capillary lumens were filled by
proliferating mesangial cells. Indeed glomerular staining with
monoclonal antibodies against various lymphocyte types was
negative in normotensive as well as in hypertensive C5S and
C5D mice. This suggests that the increased glomenilar capillary
cellularity was not due to blood-borne leukocytes but to prolif-
eration of resident glomerular cells. Furthermore, by electron
microscopy polymorphonuclear leukocytes and monocytes
were not seen in either DOCA-CSS or -C5D mice at either four
or 16 weeks. Proliferating cells, which were particularly in-
creased in DOCA-CSS mice, appeared to be primarily mesan-
gial cells. Increased proliferation of glomerular mesangial cells
in C5S mice compared with C5D mice has also been observed in
a model of immune complex glomerular disease [37]. Recently,
Lovett et al have shown in in vitro experiments that sublytic
amounts of C5b-9 stimulate mesangial cells to produce interleu-
kin I, a powerful growth factor [II].
C3 was not present in glomeruli of normotensive mice.
However, we observed C3 deposition in the mesangium of both
DOCA-C5S and -C5D mice. Moreover, C9 was present in
DOCA-C5S mice but was absent in DOCA-C5D mice. Since
DOCA-CSD mice showed much milder mesangial proliferation,
we hypothesize that in situ activation of C5-9 may have
provided an important stimulus for mesangial cell proliferation
in hypertensive DOCA-C5S mice [Il]. Whether the increased
staining of 1gM and C3 in hypertensive C5D mice represents
increased deposition and/or trapping or decreased removal of
these proteins is at present unclear.
Progressive dilatation of capillary loops in the presence of
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Fig. 6. Electron micrograph of a glomerulus from a hypertensive DOA-NaCl CS-deficient mouse shows dilatation of capillary lumens (CL) and
focal detachment (arrow) of the glomerular basement membrane from the mesangiu,n (M). Magnification x3600.
continuously high intracapillary pressure should increase the
tension of the capillary wall according to La Place law. Given
the marked dilatation of capillary loops and concomitant in-
crease in glomerular capillary volumes observed in DOCA-C5D
mice, it is reasonable to infer that the capillary wall tension
would be higher in these mice. In both DOCA-C5S and -C5D
mice detachment of endothelial cells was observed. However,
gaps in the glomerular basement membrane were noted only in
DOCA-C5S mice. Moreover, glomerular crescents, which are
associated with capillary rupture, were more common in
DOCA-C5S mice than in DOCA-C5D mice. The above de-
scribed findings would suggest that a) increased capillary wall
tension and dilatation may not play a relevant role in this model
of hypertensive glomerular injury and/or b) that terminal com-
plement components are pathogenetically important in the
mediation or amplification of glomerular damage observed in
C5S mice.
Platelets might participate in the production of complement
dependent renal damage in hypertension. It is known that the
MAC is capable of interacting with platelets, causing their
activation [38, 39]. Platelet activation by the MAC may result in
release of mitogenic substances in the glomerulus that could
contribute to glomerular cell proliferation [40]. Thus the differ-
ences in renal lesions between C5D and C5S mice might be
mediated, at least in part, by complement-dependent platelet
activation. Fibrin and leukocytes, primarily monocytes, were
observed in the crescents by both electron microscopy and
immunofluorescent staining using monoclonal antibodies. Sim-
ilar findings have been observed in other types of glomerular
injury in which extraglomerular capillary crescents are formed.
The reason for the absence of leukocytes in intracapillary
locations in DOCA-C5S mice is unclear. This does not appear
to be due to abnormal leukocyte function since Falk and
Jennette found leukocytes in the glomeruli of C5S mice with
immune complex glomerulonephritis [37].
Associated with the more severe glomerular injury at four
weeks of treatment, DOCA-C5S mice had higher urinary pro-
tein excretion than C5S mice. At this time, however, serum
creatinine levels were similar in all groups whether normoten-
sive or hypertensive (Table I). To determine if the differences at
four weeks between C5S and C5D mice were only transient,
and if protracted injury would result in progressive glomerular
destruction and abnormal renal function, we studied C5S and
C5D mice given DOCA-NaCI for 16 weeks. Similar blood
pressures were recorded in mice that received DOCA for 16
weeks or for only four weeks. At 16 weeks DOCA-C5D mice
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continued to have aneurysmal dilatation of the capillary loops,
discrete intraglomerular capillary proliferation and minimal
crescents. In these mice the injury score for glomerulosclerosis
was low. On the other hand, DOCA-C5S mice developed severe
glomerulosclerosis. In addition, at 16 weeks tubulointerstitial
changes were minimal in DOCA-C5D mice but moderately
severe in DOCA-C5S mice. At 16 weeks both the urinary
protein excretion and the serum creatinine of DOCA-C5S mice
were significantly higher than in C5D mice, indicating more
severe renal damage in C5S mice.
In conclusion, our findings in hypertensive C5S and C5D
mice suggest that a) C5-9 may participate in the initiation and/or
amplification of the hemodynamically-mediated glomerular in-
jury of hypertension which ultimately results in glomeruloscler-
osis and renal insufficiency, b) provide insight into the clinically
and experimentally observed synergistic interaction between
immune mediated and hypertensive glomerular injury [16—19],
and c) emphasize the importance of differences in host re-
sponses in determining target organ susceptibility to similar
injurious mechanisms.
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